Envestnet Asset Management’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $455K | Sell |
17,765
-1,034
| -6% | -$26.5K | ﹤0.01% | 3763 |
|
2025
Q1 | $517K | Buy |
18,799
+2,396
| +15% | +$65.9K | ﹤0.01% | 3600 |
|
2024
Q4 | $442K | Buy |
16,403
+2,384
| +17% | +$64.3K | ﹤0.01% | 3648 |
|
2024
Q3 | $404K | Buy |
+14,019
| New | +$404K | ﹤0.01% | 3650 |
|
2022
Q2 | – | Sell |
-20,230
| Closed | -$538K | – | 3964 |
|
2022
Q1 | $538K | Buy |
+20,230
| New | +$538K | ﹤0.01% | 3083 |
|